Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin

BACKGROUND: The sodium-glucose co-transporter-2 (SGLT-2) inhibitors have been reported to increase both low-density lipoprotein (LDL) and high-density lipoprotein (HDL)-cholesterol (C). This study aimed to determine how SGLT-2 inhibitors affect LDL and HDL-C subspecies. METHODS: This single center,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayashi, Toshiyuki, Fukui, Tomoyasu, Nakanishi, Noriko, Yamamoto, Saki, Tomoyasu, Masako, Osamura, Anna, Ohara, Makoto, Yamamoto, Takeshi, Ito, Yasuki, Hirano, Tsutomu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237208/
https://www.ncbi.nlm.nih.gov/pubmed/28086872
http://dx.doi.org/10.1186/s12933-016-0491-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237208/
https://www.ncbi.nlm.nih.gov/pubmed/28086872
http://dx.doi.org/10.1186/s12933-016-0491-5

Ejemplares similares